Abstract
Members of the extended Fc receptor-like (FCRL) family in humans and mice are preferentially expressed by B cells and possess tyrosine-based immunoregulatory function. Although the majority of these proteins repress B cell receptor-mediated activation, there is an emerging evidence for their bifunctionality and capacity to counter-regulate adaptive and innate signaling pathways. In light of these findings, the recent discovery of ligands for several of these molecules has begun to reveal exciting potential for them in normal lymphocyte biology and is launching a new phase of FCRL investigation. Importantly, these fundamental developments are also setting the stage for defining their altered roles in the pathogenesis of a growing number of immune-mediated diseases. Here we review recent advances in the FCRL field and highlight the significance of these intriguing receptors in normal and perturbed immunobiology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503–511
Arthos J, Cicala C, Martinelli E, Macleod K, Van Ryk D, Wei D et al (2008) HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol 9:301–309
Bajpai UD, Swainson LA, Mold JE, Graf JD, Imboden JB, McCune JM (2012) A functional variant in FCRL3 is associated with higher Fc receptor-like 3 expression on T cell subsets and rheumatoid arthritis disease activity. Arthritis Rheum 64:2451–2459
Bruhns P, Iannascoli B, England P, Mancardi DA, Fernandez N, Jorieux S et al (2009) Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 113:3716–3725
Campbell JA, Davis RS, Lilly LM, Fremont DH, French AR, Carayannopoulos LN (2010) Cutting edge: FcR-like 5 on innate B cells is targeted by a poxvirus MHC class I-like immunoevasin. J Immunol 185:28–32
Campbell JA, Trossman DS, Yokoyama WM, Carayannopoulos LN (2007) Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D. J Exp Med 204:1311–1317
Capolunghi F, Cascioli S, Giorda E, Rosado MM, Plebani A, Auriti C et al (2008) CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J Immunol 180:800–808
Cerutti A, Cols M, Puga I (2013) Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat Rev Immunol 13:118–132
Chan VW, Meng F, Soriano P, DeFranco AL, Lowell CA (1997) Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7:69–81
Charles ED, Green RM, Marukian S, Talal AH, Lake-Bakaar GV, Jacobson IM et al (2008) Clonal expansion of immunoglobulin M + CD27 + B cells in HCV-associated mixed cryoglobulinemia. Blood 111:1344–1356
Chikaev NA, Bykova EA, Najakshin AM, Mechetina LV, Volkova OY, Peklo MM et al (2005) Cloning and characterization of the human FCRL2 gene. Genomics 85:264–272
Chistiakov DA, Chistiakov AP (2007) Is FCRL3 a new general autoimmunity gene? Hum Immunol 68:375–383
Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL et al (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94:1840–1847
Davis RS, Dennis G Jr, Odom MR, Gibson AW, Kimberly RP, Burrows PD et al (2002a) Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family. Immunol Rev 190:123–136
Davis RS, Li H, Chen CC, Wang YH, Cooper MD, Burrows PD (2002b) Definition of an Fc receptor-related gene (FcRX) expressed in human and mouse B cells. Int Immunol 14:1075–1083
Davis RS, Stephan RP, Chen CC, Dennis G Jr, Cooper MD (2004) Differential B cell expression of mouse Fc receptor homologs. Int Immunol 16:1343–1353
Davis RS, Wang YH, Kubagawa H, Cooper MD (2001) Identification of a family of Fc receptor homologs with preferential B cell expression. Proc Natl Acad Sci USA 98:9772–9777
Dement-Brown J, Newton CS, Ise T, Damdinsuren B, Nagata S, Tolnay M (2012) Fc receptor-like 5 promotes B cell proliferation and drives the development of cells displaying switched isotypes. J Leukoc Biol 91:59–67
Du X, Nagata S, Ise T, Stetler-Stevenson M, Pastan I (2008) FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins. Blood 111:338–343
Ehrhardt GR, Cooper MD (2011) Immunoregulatory roles for fc receptor-like molecules. Curr Top Microbiol Immunol 350:89–104
Ehrhardt GR, Davis RS, Hsu JT, Leu CM, Ehrhardt A, Cooper MD (2003) The inhibitory potential of Fc receptor homolog 4 on memory B cells. Proc Natl Acad Sci U S A 100:13489–13494
Ehrhardt GR, Hijikata A, Kitamura H, Ohara O, Wang JY, Cooper MD (2008) Discriminating gene expression profiles of memory B cell subpopulations. J Exp Med 205:1807–1817
Ehrhardt GR, Hsu JT, Gartland L, Leu CM, Zhang S, Davis RS et al (2005) Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J Exp Med 202:783–791
Elkins K, Zheng B, Go M, Slaga D, Du C, Scales SJ et al (2012) FcRL5 as a target of antibody-drug conjugates for the treatment of multiple myeloma. Mol Cancer Ther 11:2222–2232
Facchetti F, Cella M, Festa S, Fremont DH, Colonna M (2002) An unusual Fc receptor-related protein expressed in human centroblasts. Proc Natl Acad Sci USA 99:3776–3781
Falini B, Agostinelli C, Bigerna B, Pucciarini A, Pacini R, Tabarrini A et al (2012) IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas. Histopathology 61:930–941
Falini B, Tiacci E, Pucciarini A, Bigerna B, Kurth J, Hatzivassiliou G et al (2003) Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). Blood 102:3684–3692
Forconi F, Sahota SS, Raspadori D, Mockridge CI, Lauria F, Stevenson FK (2001) Tumor cells of hairy cell leukemia express multiple clonally related immunoglobulin isotypes via RNA splicing. Blood 98:1174–1181
Franco A, Damdinsuren B, Ise T, Dement-Brown J, Li H, Nagata S et al (2013) Human Fc receptor-like 5 binds intact IgG via mechanisms distinct from those of Fc receptors. J Immunol 190:5739–5746
Gibson AW, Li FJ, Wu JM, Edberg JC, Su KH, Cafardi J et al (2009) The FCRL3-169CT promoter single-nucleotide polymorphism, which is associated with systemic lupus erythematosus in a Japanese population, predicts expression of receptor protein on CD19 + B cells. Arthritis Rheum 60:3510–3512
Guselnikov SV, Ershova SA, Mechetina LV, Najakshin AM, Volkova OY, Alabyev BY et al (2002) A family of highly diverse human and mouse genes structurally links leukocyte FcR, gp42 and PECAM-1. Immunogenetics 54:87–95
Haga CL, Ehrhardt GR, Boohaker RJ, Davis RS, Cooper MD (2007) Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment. Proc Natl Acad Sci U S A 104:9770–9775
Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94:1848–1854
Hatzivassiliou G, Miller I, Takizawa J, Palanisamy N, Rao PH, Iida S et al (2001) IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity 14:277–289
Imboden JB, Eriksson EC, McCutcheon M, Reynolds CW, Seaman WE (1989) Identification and characterization of a cell-surface molecule that is selectively induced on rat lymphokine-activated killer cells. J Immunol 143:3100–3103
Inozume T, Matsuzaki Y, Kurihara S, Fujita T, Yamamoto A, Aburatani H et al (2005) Novel melanoma antigen, FCRL/FREB, identified by cDNA profile comparison using DNA chip are immunogenic in multiple melanoma patients. Int J Cancer 114:283–290
Ise T, Maeda H, Santora K, Xiang L, Kreitman RJ, Pastan I et al (2005) Immunoglobulin superfamily receptor translocation associated 2 protein on lymphoma cell lines and hairy cell leukemia cells detected by novel monoclonal antibodies. Clin Cancer Res 11:87–96
Ise T, Nagata S, Kreitman RJ, Wilson WH, Wayne AS, Stetler-Stevenson M et al (2007) Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma. Leukemia 21:169–174
Jackson TA, Haga CL, Ehrhardt GR, Davis RS, Cooper MD (2010) FcR-Like 2 Inhibition of B Cell Receptor-Mediated Activation of B Cells. J Immunol 185:7405–7412
Jelicic K, Cimbro R, Nawaz F, Huang DW, Zheng X, Yang J et al (2013) The HIV-1 envelope protein gp120 impairs B cell proliferation by inducing TGF-beta1 production and FcRL4 expression. Nat Immunol 14(12):1256–1265
Kardava L, Moir S, Wang W, Ho J, Buckner CM, Posada JG et al (2011) Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors. J Clin Invest 121:2614–2624
Kehrl JH, Thevenin C, Rieckmann P, Fauci AS (1991) Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA. J Immunol 146:4016–4023
Kochi Y, Myouzen K, Yamada R, Suzuki A, Kurosaki T, Nakamura Y et al (2009) FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling. J Immunol 183:5502–5510
Kochi Y, Yamada R, Suzuki A, Harley JB, Shirasawa S, Sawada T et al (2005) A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 37:478–485
Kulemzin SV, Zamoshnikova AY, Yurchenko MY, Vitak NY, Najakshin AM, Fayngerts SA et al (2011) FCRL6 receptor: expression and associated proteins. Immunol Lett 134:174–182
Leu CM, Davis RS, Gartland LA, Fine WD, Cooper MD (2005) FcRH1: an activation coreceptor on human B cells. Blood 105:1121–1126
Li FJ, Ding S, Pan J, Shakhmatov MA, Kashentseva E, Wu J et al (2008) FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia. Blood 112:179–187
Li FJ, Schreeder DM, Li R, Wu J, Davis RS (2013) FCRL3 promotes TLR9-induced B-cell activation and suppresses plasma cell differentiation. Eur J Immunol 43:2980–2992
Maehlen MT, Nordang GB, Syversen SW, van der Heijde DM, Kvien TK, Uhlig T et al (2011) FCRL3 -169C/C genotype is associated with anti-citrullinated protein antibody-positive rheumatoid arthritis and with radiographic progression. J Rheumatol 38:2329–2335
Maltais LJ, Lovering RC, Taranin AV, Colonna M, Ravetch JV, Dalla-Favera R et al (2006) New nomenclature for Fc receptor-like molecules. Nat Immunol 7:431–432
Martin F, Kearney JF (2000) B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a “natural immune memory”. Immunol Rev 175:70–79
Masir N, Jones M, Pozzobon M, Marafioti T, Volkova OY, Mechetina LV et al (2004) Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells. Br J Haematol 127:335–343
Masuda K, Davis RS, Maruyama T, Zhang J, He T, Cooper MD et al (2005) FcRY, an Fc receptor related gene differentially expressed during B lymphocyte development and activation. Gene 363:32–40
Masuda K, Mori H, Ohara O, Nakayama M, Wang JY, Burrows PD (2010) Defining the immunological phenotype of Fc receptor-like B (FCRLB) deficient mice: confounding role of the inhibitory FcgammaRIIb. Cell Immunol 266:24–31
Mechetina LV, Najakshin AM, Volkova OY, Guselnikov SV, Faizulin RZ, Alabyev BY et al (2002) FCRL, a novel member of the leukocyte Fc receptor family possesses unique structural features. Eur J Immunol 32:87–96
Miller I, Hatzivassiliou G, Cattoretti G, Mendelsohn C, Dalla-Favera R (2002) IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells. Blood 99:2662–2669
Mohan J, Dement-Brown J, Maier S, Ise T, Kempkes B, Tolnay M (2006) Epstein-Barr virus nuclear antigen 2 induces FcRH5 expression through CBF1. Blood 107:4433–4439
Moir S, Ho J, Malaspina A, Wang W, DiPoto AC, O’Shea MA et al (2008) Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 205:1797–1805
Nagata S, Ise T, Pastan I (2009) Fc receptor-like 3 protein expressed on IL-2 nonresponsive subset of human regulatory T cells. J Immunol 182:7518–7526
Nakayama Y, Weissman SM, Bothwell AL (2001) BXMAS1 identifies a cluster of homologous genes differentially expressed in B cells. Biochem Biophys Res Commun 285:830–837
Okazaki T, Maeda A, Nishimura H, Kurosaki T, Honjo T (2001) PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci U S A 98:13866–13871
Polson AG, Zheng B, Elkins K, Chang W, Du C, Dowd P et al (2006) Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia. Int Immunol 18:1363–1373
Pritchard NR, Cutler AJ, Uribe S, Chadban SJ, Morley BJ, Smith KG (2000) Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcgammaRII. Curr Biol 10:227–230
Rakhmanov M, Keller B, Gutenberger S, Foerster C, Hoenig M, Driessen G et al (2009) Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc Natl Acad Sci U S A 106:13451–13456
Rassenti LZ, Jain S, Keating MJ, Wierda WG, Grever MR, Byrd JC et al (2008) Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. Blood 112:1923–1930
Reshetnikova ES, Mechetina LV, Volkova OY, Guselnikov SV, Chikaev NA, Kovesdi D et al (2012) Differential expression of FCRLA in naive and activated mouse B cells. Cell Immunol 272:182–192
Rui L, Healy JI, Blasioli J, Goodnow CC (2006) ERK signaling is a molecular switch integrating opposing inputs from B cell receptor and T cell cytokines to control TLR4-driven plasma cell differentiation. J Immunol 177:5337–5346
Rui L, Vinuesa CG, Blasioli J, Goodnow CC (2003) Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling. Nat Immunol 4:594–600
Santiago T, Kulemzin SV, Reshetnikova ES, Chikaev NA, Volkova OY, Mechetina LV et al (2011) FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA. Int Immunol 23:43–53
Schreeder DM, Cannon JP, Wu J, Li R, Shakhmatov MA, Davis RS (2010) Cutting edge: FcR-like 6 is an MHC class II receptor. J Immunol 185:23–27
Schreeder DM, Pan J, Li FJ, Vivier E, Davis RS (2008) FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia. Eur J Immunol 38:3159–3166
Seaman WE, Niemi EC, Stark MR, Goldfien RD, Pollock AS, Imboden JB (1991) Molecular cloning of gp42, a cell-surface molecule that is selectively induced on rat natural killer cells by interleukin 2: glycolipid membrane anchoring and capacity for transmembrane signaling. J Exp Med 173:251–260
Shultz LD, Schweitzer PA, Rajan TV, Yi T, Ihle JN, Matthews RJ et al (1993) Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73:1445–1454
Sohn HW, Krueger PD, Davis RS, Pierce SK (2011) FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling. Blood 118:6332–6341
Swainson LA, Mold JE, Bajpai UD, McCune JM (2010) Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1. J Immunol 184:3639–3647
Weiss GE, Crompton PD, Li S, Walsh LA, Moir S, Traore B et al (2009) Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J Immunol 183:2176–2182
Weller S, Braun MC, Tan BK, Rosenwald A, Cordier C, Conley ME et al (2004) Human blood IgM “memory” B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104:3647–3654
Wherry EJ, Ha SJ, Kaech SM, Haining WN, Sarkar S, Kalia V et al (2007) Molecular signature of CD8 + T cell exhaustion during chronic viral infection. Immunity 27:670–684
Wilson TJ, Colonna M (2005) A new Fc receptor homolog, FREB2, found in germinal center B cells. Genes Immun 6:341–346
Wilson TJ, Fuchs A, Colonna M (2012) Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG. J Immunol 188:4741–4745
Wilson TJ, Gilfillan S, Colonna M (2010) Fc receptor-like A associates with intracellular IgG and IgM but is dispensable for antigen-specific immune responses. J Immunol 185:2960–2967
Wilson TJ, Presti RM, Tassi I, Overton ET, Cella M, Colonna M (2007) FcRL6, a new ITIM-bearing receptor on cytolytic cells, is broadly expressed by lymphocytes following HIV-1 infection. Blood 109:3786–3793
Won WJ, Foote JB, Odom MR, Pan J, Kearney JF, Davis RS (2006) Fc receptor homolog 3 is a novel immunoregulatory marker of marginal zone and B1 B cells. J Immunol 177:6815–6823
Xiu Y, Nakamura K, Abe M, Li N, Wen XS, Jiang Y et al (2002) Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses. J Immunol 169:4340–4346
Xu MJ, Zhao R, Cao H, Zhao ZJ (2002) SPAP2, an Ig family receptor containing both ITIMs and ITAMs. Biochem Biophys Res Commun 293:1037–1046
Xu MJ, Zhao R, Zhao ZJ (2001) Molecular cloning and characterization of SPAP1, an inhibitory receptor. Biochem Biophys Res Commun 280:768–775
Yang Y, Su X, Zhang K, Zhou R (2013) The Fc receptor-like 3 gene polymorphisms and susceptibility to autoimmune diseases: an updated meta-analysis. Autoimmunity 46:547–558
Yasuda T, Kometani K, Takahashi N, Imai Y, Aiba Y, and Kurosaki T (2011) ERKs induce expression of the transcriptional repressor Blimp-1 and subsequent plasma cell differentiation. Sci Signal 4:ra25
Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, Altman JD et al (1998) Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 188:2205–2213
Zhao SX, Liu W, Zhan M, Song ZY, Yang SY, Xue LQ et al (2013) A refined study of FCRL genes from a genome-wide association study for Graves’ disease. PLoS ONE 8:e57758
Zhu Z, Li R, Li H, Zhou T, Davis RS (2013) FCRL5 exerts binary and compartment-specific influence on innate-like B-cell receptor signaling. Proc Natl Acad Sci U S A 110:E1282–E1290
Acknowledgments
P.D.B. was supported by NIH grant AI100076. R.S.D. was supported by funding from the Lupus Research Institute, the UAB Center for AIDS Research (AI027767), and NIH grants AI097729, CA175912, and CA161731.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Li, F.J. et al. (2014). Emerging Roles for the FCRL Family Members in Lymphocyte Biology and Disease. In: Daeron, M., Nimmerjahn, F. (eds) Fc Receptors. Current Topics in Microbiology and Immunology, vol 382. Springer, Cham. https://doi.org/10.1007/978-3-319-07911-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-07911-0_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-07910-3
Online ISBN: 978-3-319-07911-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)